pyridoxal phosphate has been researched along with Hypesthesia in 1 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coriat, R | 1 |
| Alexandre, J | 1 |
| Nicco, C | 1 |
| Quinquis, L | 1 |
| Benoit, E | 1 |
| Chéreau, C | 1 |
| Lemaréchal, H | 1 |
| Mir, O | 1 |
| Borderie, D | 1 |
| Tréluyer, JM | 1 |
| Weill, B | 1 |
| Coste, J | 1 |
| Goldwasser, F | 1 |
| Batteux, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Mangafodipir Protective Activity Against Oxaliplatin Neurotoxicity[NCT00727922] | Phase 2 | 23 participants (Actual) | Interventional | 2008-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pyridoxal phosphate and Hypesthesia
| Article | Year |
|---|---|
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.
Topics: Action Potentials; Administration, Intravenous; Aged; Animals; Antineoplastic Agents; Antioxidants; | 2014 |